• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血清碳酸氢盐的腹膜透析起始后心血管事件预测模型。

A predictive model based on serum bicarbonate for cardiovascular events after initiation of peritoneal dialysis.

机构信息

Department of Nephropathy, The First Affiliated Hospital of Anhui Medical University, Hefei, China.

Center for Scientific Research of Anhui Medical University, Hefei, China.

出版信息

Ren Fail. 2024 Dec;46(2):2422428. doi: 10.1080/0886022X.2024.2422428. Epub 2024 Nov 4.

DOI:10.1080/0886022X.2024.2422428
PMID:39494539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11536655/
Abstract

BACKGROUND

The risk of cardiovascular events (CVEs) in peritoneal dialysis (PD) patients is high, but varies widely among individuals. Metabolic acidosis is prevalent in PD patients and may be involved in the development of CVEs. The aim of the study was to evaluate serum bicarbonate as a risk factor and derive a model of new CVE.

METHODS

A predictive model was established by performing an observational study in 187 PD patients obtained from the First Affiliated Hospital of Anhui Medical University. The variables were extracted using least absolute shrinkage and selection operator (LASSO) regression, and the modeling was developed using multivariable Cox regression.

RESULTS

Left ventricular hypertrophy (HR = 1.965, 95%CI 1.086-3.557) and history of CVEs (HR = 2.435, 95%CI 1.342-4.49) were risk parameters for a new CVE. Serum albumin (HR = 0.924, 95%CI 0.864-0.989) and bicarbonate levels (HR = 0.817, 95%CI 0.689-0.969) were protective parameters, in which the risk of CVEs was reduced by 7.6% and 18.3% for each 1-unit increase in serum albumin (g/L) and bicarbonate (mmol/L) levels, respectively. A nomogram based on the above predictive indicators was proposed with a -statistic of 0.806, indicating good discrimination. Moreover, it successfully stratified patients into low-, intermediate-, and high-risk groups.

CONCLUSIONS

We performed a risk prediction model for the development of CVEs in patients with PD, which may help physicians to evaluate the risk of new CVEs and provide a scientific basis for further interventions. Further studies are needed to externally validate current risk models before clinical application.

摘要

背景

腹膜透析(PD)患者发生心血管事件(CVE)的风险较高,但个体间差异很大。代谢性酸中毒在 PD 患者中很常见,可能与 CVE 的发生有关。本研究旨在评估血清碳酸氢盐作为危险因素,并建立新的 CVE 预测模型。

方法

对安徽医科大学第一附属医院的 187 例 PD 患者进行观察性研究,采用最小绝对收缩和选择算子(LASSO)回归提取变量,多变量 Cox 回归建立模型。

结果

左心室肥厚(HR=1.965,95%CI 1.086-3.557)和 CVE 病史(HR=2.435,95%CI 1.342-4.49)是新 CVE 的危险因素。血清白蛋白(HR=0.924,95%CI 0.864-0.989)和碳酸氢盐水平(HR=0.817,95%CI 0.689-0.969)是保护因素,血清白蛋白(g/L)和碳酸氢盐(mmol/L)水平每增加 1 单位,CVE 风险分别降低 7.6%和 18.3%。基于上述预测指标建立了一个列线图,C 统计量为 0.806,表明具有良好的区分度。此外,该列线图能够成功地将患者分为低危、中危和高危组。

结论

本研究建立了 PD 患者 CVE 发生风险的预测模型,有助于医生评估新 CVE 的风险,并为进一步干预提供科学依据。在临床应用之前,还需要进一步的研究来对外科验证当前的风险模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/1c39946ded49/IRNF_A_2422428_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/52d1309dadde/IRNF_A_2422428_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/4e1190f88558/IRNF_A_2422428_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/638f7d749f15/IRNF_A_2422428_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/2744b7994651/IRNF_A_2422428_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/1c39946ded49/IRNF_A_2422428_F0005_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/52d1309dadde/IRNF_A_2422428_F0001_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/4e1190f88558/IRNF_A_2422428_F0002_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/638f7d749f15/IRNF_A_2422428_F0003_B.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/2744b7994651/IRNF_A_2422428_F0004_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c57/11536655/1c39946ded49/IRNF_A_2422428_F0005_C.jpg

相似文献

1
A predictive model based on serum bicarbonate for cardiovascular events after initiation of peritoneal dialysis.基于血清碳酸氢盐的腹膜透析起始后心血管事件预测模型。
Ren Fail. 2024 Dec;46(2):2422428. doi: 10.1080/0886022X.2024.2422428. Epub 2024 Nov 4.
2
Prognostic significance of concentric left ventricular hypertrophy at peritoneal dialysis initiation.腹膜透析起始时的向心性左心室肥厚的预后意义。
BMC Nephrol. 2021 Apr 16;22(1):135. doi: 10.1186/s12882-021-02321-1.
3
Metabolic Acidosis 1 Year Following Kidney Transplantation and Subsequent Cardiovascular Events and Mortality: An Observational Cohort Study.肾移植后 1 年发生代谢性酸中毒与随后的心血管事件和死亡:一项观察性队列研究。
Am J Kidney Dis. 2019 Apr;73(4):476-485. doi: 10.1053/j.ajkd.2018.12.023. Epub 2019 Jan 28.
4
The association of left ventricular fraction shortening with cardiovascular events in peritoneal dialysis patients.左心室缩短分数与腹膜透析患者心血管事件的相关性。
Ren Fail. 2023;45(2):2261786. doi: 10.1080/0886022X.2023.2261786. Epub 2023 Oct 1.
5
Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.循环可溶性血管细胞黏附分子1:与腹膜透析患者残余肾功能、心脏肥大及预后的关系
Am J Kidney Dis. 2005 Apr;45(4):715-29. doi: 10.1053/j.ajkd.2004.12.012.
6
Associations of vitamin K status with mortality and cardiovascular events in peritoneal dialysis patients.维生素 K 状态与腹膜透析患者死亡率和心血管事件的关系。
Int Urol Nephrol. 2019 Mar;51(3):527-534. doi: 10.1007/s11255-019-02080-x. Epub 2019 Jan 28.
7
Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.血清碳酸氢盐与慢性肾脏病患者肾脏和心血管结局风险的关系:来自慢性肾功能不全队列(CRIC)研究的报告。
Am J Kidney Dis. 2013 Oct;62(4):670-8. doi: 10.1053/j.ajkd.2013.01.017. Epub 2013 Mar 13.
8
Metabolic acidosis in peritoneal dialysis patients: the role of residual renal function.腹膜透析患者的代谢性酸中毒:残余肾功能的作用。
Blood Purif. 2005;23(6):459-65. doi: 10.1159/000088989. Epub 2005 Oct 18.
9
Clinical experience with a new bicarbonate (25 mmol/L)/lactate (10 mmol/L) peritoneal dialysis solution.一种新型碳酸氢盐(25毫摩尔/升)/乳酸盐(10毫摩尔/升)腹膜透析液的临床经验。
Perit Dial Int. 2003 Mar-Apr;23(2):138-45.
10
Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.心血管事件对透析前慢性肾脏病患者终末期肾病及死亡率的影响。
Ther Apher Dial. 2016 Feb;20(1):12-9. doi: 10.1111/1744-9987.12332. Epub 2015 Dec 17.

本文引用的文献

1
Exploring the Relationship Between Intensive Blood Pressure Lowering, Left Ventricular Hypertrophy, and Cardiovascular Outcomes.探索强化降压、左心室肥厚与心血管结局之间的关系。
Hypertension. 2023 Sep;80(9):1843-1844. doi: 10.1161/HYPERTENSIONAHA.123.21512. Epub 2023 Aug 16.
2
Incidence of Chronic Kidney Disease among Adults with Diabetes, 2015-2020.2015 - 2020年糖尿病成年患者慢性肾脏病的发病率
N Engl J Med. 2022 Oct 13;387(15):1430-1431. doi: 10.1056/NEJMc2207018.
3
A nomogram predicts cardiovascular events in patients with peritoneal dialysis-associated peritonitis.
列线图预测腹膜透析相关性腹膜炎患者的心血管事件。
Ren Fail. 2022 Dec;44(1):1558-1567. doi: 10.1080/0886022X.2022.2126785.
4
Metabolic Acidosis and Cardiovascular Disease in CKD.慢性肾脏病中的代谢性酸中毒与心血管疾病
Kidney Med. 2021 Jun 27;3(5):753-761.e1. doi: 10.1016/j.xkme.2021.04.011. eCollection 2021 Sep-Oct.
5
Chronic Kidney Disease: Strategies to Retard Progression.慢性肾脏病:延缓进展的策略。
Int J Mol Sci. 2021 Sep 18;22(18):10084. doi: 10.3390/ijms221810084.
6
Systematic Review and Meta-Analysis of Renin-Angiotensin-Aldosterone System Blocker Effects on the Development of Cardiovascular Disease in Patients With Chronic Kidney Disease.肾素-血管紧张素-醛固酮系统阻滞剂对慢性肾脏病患者心血管疾病发生影响的系统评价与荟萃分析
Front Pharmacol. 2021 Jul 2;12:662544. doi: 10.3389/fphar.2021.662544. eCollection 2021.
7
Reactivity of skin microcirculation as a biomarker of cardiovascular events. Pilot study.皮肤微循环反应作为心血管事件的生物标志物的反应性。初步研究。
Clin Hemorheol Microcirc. 2021;78(3):247-257. doi: 10.3233/CH-201016.
8
Association of sclerostin with cardiovascular events and mortality in dialysis patients.硬骨素与透析患者心血管事件和死亡的相关性。
Ren Fail. 2020 Nov;42(1):282-288. doi: 10.1080/0886022X.2020.1741386.
9
Nomogram for Predicting Cardiovascular Mortality in Incident Peritoneal Dialysis Patients: An Observational Study.列线图预测腹膜透析患者心血管死亡率:一项观察性研究。
Sci Rep. 2017 Oct 24;7(1):13889. doi: 10.1038/s41598-017-14489-4.
10
Hypervolemia, hypoalbuminemia and mitral calcification as markers of cardiovascular risk in peritoneal dialysis patients.高血容量、低白蛋白血症和二尖瓣钙化作为腹膜透析患者心血管风险的标志物。
Rev Port Cardiol. 2017 Sep;36(9):599-604. doi: 10.1016/j.repc.2016.12.014. Epub 2017 Aug 23.